Docetaxel plus fractionated cisplatin is a safe and active schedule as first-line treatment of patients with advanced non-small cell lung cancer: results of a phase II study
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Margarita Amenedo |
| Publication date | November 1, 2004 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |